SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 13,714.73 |
Enterprise Value ($M) | 23,793.92 |
Book Value ($M) | 10,258.47 |
Book Value / Share | 23.67 |
Price / Book | 1.34 |
NCAV ($M) | -6,078.21 |
NCAV / Share | -14.03 |
Price / NCAV | -2.26 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.05 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.09 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.44 |
Current Ratio | 1.44 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,802.14 |
Assets | 18,222.72 |
Liabilities | 7,880.35 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2,263.00 |
Operating Income | 1,292.00 |
Net Income | 859.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 2,769.00 |
Cash from Investing | -2,678.00 |
Cash from Financing | 361.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Severgnini Achille G. | 8.30 | -13.56 | |
13G/A | Fmr Llc | 5.90 | -16.70 | |
13G | BlackRock, Inc. | 5.70 | ||
13G/A | Morgan Stanley | 8.20 | -11.28 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
900,476 | 3,242,452 | 27.77 | |
2,712,633 | 6,641,679 | 40.84 | |
716,570 | 3,890,310 | 18.42 | |
355,210 | 1,574,277 | 22.56 | |
(click for more detail) |
Similar Companies | |
---|---|
RLMD – Relmada Therapeutics, Inc. | RLYB – Rallybio Corporation |
ROIV – Roivant Sciences Ltd. | RPTX – Repare Therapeutics Inc. |
RVMD – Revolution Medicines, Inc. |
Financial data and stock pages provided by
Fintel.io